FDA
-
-
-
-
-
-
-
UPDATE: Amgen (AMGN) to Acquire ChemoCentryx (CCXI) in $3.7bn Deal
-
-
-
-
-
-
-
ChemoCentryx Announces Presentation at the Society for Investigative Dermatology Meeting Highlighting the Role of Tunnels in Driving Ongoing Disease in Hidradenitis Suppurativa
-
-
-
-
-
-
-
Pre-Open Stock Movers 03/02: (JWN) (SOFI) (ARDX) Higher; (KPTI) (GOCO) (DIBS) Lower (more...)
-
-
-
-
-
-
-
ChemoCentryx (CCXI) Announces Positive CHMP Recommendation for Use of TAVNEOS in ANCA Vasculitis
-
-
-
-
-
-
-
ChemoCentryx (CCXI) PT Raised to $85 at Stifel
-
-
-
-
-
-
-
After-Hours Stock Movers 10/07: (MNTV) (QDEL) Higher; (ALLO) (AGRX) (CDTX) Lower (more...)
-
-
-
-
-
-
-
Stifel Upgrades ChemoCentryx (CCXI) to Buy on Amendment To Avacopan NDA
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

